Araştırma Makalesi

IR spektroskopi kullanılarak in vitro meme kanser kök hücrelerinin araştırılması

Cilt: 59 Sayı: 3 30 Eylül 2020
PDF İndir
EN TR

Investigation of breast cancer stem cells in vitro by using IR spectroscopy

Abstract

Aim: Cancer stem cells (CSCs) lead to tumor initiation, progression, relapse, metastasis and therapeutic resistance due to the ability of tumor to self-renewal and differentiate into other cell types. Therefore, the characteristic features of breast CSCs need to be determined in detail. The aim of this study was to investigate the differences in cell biochemistry at the molecular level by using Fourier transform infrared (FTIR) spectroscopy after breast CSCs were isolated with flow cytometry. Materials and Methods: Breast CSCs with CD44+/CD24- surface marker properties in the MCF-7 cancer cell lines were isolated by using flow cytometry (FACS). MCF10A, MCF-7 breast cancer cell line (cancer non-stem cells or non-CSCs) and breast CSCs were re-suspended into 0.9% NaCl, and each cell type was measured with the FTIR spectrometer. Results: The portion of breast CSCs with CD44+/CD24- surface marker properties in MCF-7 was 2.0-2.3%. In the FTIR spectra, spectral similarities and differences among breast CSCs, non-CSCs and healthy cells were determined. In breast CSCs, the lipid and protein signals are quite strong accompanied with an increased cell membrane fluidity and dynamics. When non-CSCs are compared with healthy cells, a less amount of both α-helical proteins and DNA is detected while an increase in the signals of negatively charged carboxyl groups is noticed. These data clearly show that breast CSCs exhibit a very different profile in terms of structure, content and dynamics of cellular macromolecules compared to both non-CSCs and healthy cells. Conclusion: Drug studies (targeted therapy, drug-action mechanism) can be performed by examining small changes in the molecular structure and content of breast CSCs. This study shows that FTIR spectroscopy can be used in advanced cell studies as well as in the analysis of biological samples in medical field due to rapid, label-free and accurate measurement without complex sample preparation procedures.

Keywords

Kaynakça

  1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68: 394–424.
  2. Siegel RL, Miller KD, Jemal A. Cancer statistics. CA Cancer J Clin 2018; 68: 7–30.
  3. Chen K, Huang Y, Chen J. Understanding and targeting cancer stem cells: therapeutic implications and challenges. Acta Pharmacol Sin 2013; 34: 732–40.
  4. Palomeras S, Ruiz-Martínez S, Puig T. Targeting Breast Cancer Stem Cells to Overcome Treatment Resistance. Molecules 2018; 23: 2193.
  5. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci 2003; 100: 3983–8.
  6. Shetty G, Kendall C, Shepherd N, Stone N, Barr H. Raman spectroscopy: elucidation of biochemical changes in carcinogenesis of oesophagus. Br J Cancer 2006; 94: 1460–4.
  7. Kumar S, Desmedt C, Larsimont D, Sotiriou C, Goormaghtigh E. Change in the microenvironment of breast cancer studied by FTIR imaging. Analyst 2013; 138: 4058–65.
  8. Güler G, Guven U, Oktem G. Characterization of CD133+/CD44+ human prostate cancer stem cells with ATR-FTIR spectroscopy. Analyst 2019; 144: 2138–49.

Ayrıntılar

Birincil Dil

Türkçe

Konular

Sağlık Kurumları Yönetimi

Bölüm

Araştırma Makalesi

Yazarlar

Ümmü Güven
0000-0002-5427-263X
Türkiye

Eda Açıkgöz
0000-0002-6772-3081
Türkiye

Gülperi Öktem
0000-0001-6227-9519
Türkiye

Yayımlanma Tarihi

30 Eylül 2020

Gönderilme Tarihi

4 Eylül 2019

Kabul Tarihi

2 Kasım 2019

Yayımlandığı Sayı

Yıl 1970 Cilt: 59 Sayı: 3

Kaynak Göster

Vancouver
1.Günnur Güler, Ümmü Güven, Eda Açıkgöz, Gülperi Öktem. IR spektroskopi kullanılarak in vitro meme kanser kök hücrelerinin araştırılması. ETD. 01 Eylül 2020;59(3):149-54. doi:10.19161/etd.790394

Ege Tıp Dergisi, makalelerin Atıf-Gayri Ticari-Aynı Lisansla Paylaş 4.0 Uluslararası (CC BY-NC-SA 4.0) lisansına uygun bir şekilde paylaşılmasına izin verir.